• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Medical Resources buys three centers

Article

Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition

Medical Resources reported last week that it has aquired three imaging centers in New York City for $5.4 million in cash and stock and the assumption of $5.3 million in debt. The combined annual revenues of the centers is $7 million, and the acquisition brings to 82 the number of centers operated by the company.

In other news, the company last month raised $26 million through an issue of senior notes to a group of insurance companies led by John Hancock Mutual Life Insurance. The Hackensack, NJ, company said it would use proceeds from the issue to fund acquisitions and for general corporate purposes. The placement brings the total amount that Medical Resources has raised this year through investment-grade senior note issues to $78 million.

In other Medical Resources news, the company acquired a controlling interest in a multimodality imaging center in midtown Manhattan. Medical Resources paid $1 million for the stake in the center, which is located within a state-of-the art medical suite to be opened by a private physician group this fall. The center is also the company's first joint venture with a physician practice management company.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.